Guardant Health Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Guardant Health Inc's ROI in the second quarter of 2026?
Guardant Health Inc recorded a cumulative net loss of $-453 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -25.34%.

Within the Healthcare sector 345 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2942 to 3515.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	48.69 %	6.63 %	-9.66 %	-22.4 %	-20.35 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	2,783	1,623	1,711	1,040	1,094
Return On Investment (TTM)	-25.34 %	-31.69 %	-33.55 %	-35.35 %	-34.39 %
GH's Overall Ranking	# 3515	# 2942	# 2660	# 1197	# 772
Seq. Investment Change TTM	30.9 %	10.17 %	9.99 %	-6.26 %	-6.13 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-453	-433	-416	-399	-414

GH Company Profile >> Back to GH Roi Comparisons >> See Annual GH Return On Investment

Return On Investment GH's Ranking
Within:	No.
Industry	# 19
Sector	# 346
Overall	# 3515

Return On Investment Statistics
High	Average	Low
-5.76 %	-25.53 %	-44.8 %
(Jun 30 2019)		(Mar 31 2023)

Financial Statements
Guardant Health Inc's II. Quarter Investments	$ 2,783 Millions	GH's Balance sheet
Guardant Health Inc's II. Quarter Income	$ -120 Millions	Quarterly GH's Income Statement
GH's Income by Division		See GH's Income by Division

GH Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	1,711	1,260	1,581	1,417	2,010
Y / Y Investment Growth	35.79 %	-20.28 %	11.56 %	-29.51 %	-8.85 %
Net Income in Millions	-416	-436	-479	-655	-385
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-24.33 %	-34.63 %	-30.34 %	-46.2 %	-19.14 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GH's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GH's Competitors
Subscribers only: Roi for Guardant Health Inc's Suppliers
Subscribers only: Return On Investment for GH's Customers

Other Ratios
GH's Roa	GH's Inventory Turnover Ratio	GH's Growth Rates	GH's Dividend Statistics
	GH's Profitability Ratios	GH's Asset Turnover Ratio	GH's Dividend Growth
GH's Roe	GH's Valuation Ratios	GH's Financial Strength Ratios	GH's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:35:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.